Journal of Proteomics
Scope & Guideline
Pioneering advancements in protein analysis and application.
Introduction
Aims and Scopes
- Comprehensive Proteomic Analyses:
The journal focuses on comprehensive proteomic analyses utilizing advanced techniques such as mass spectrometry, enabling the identification and quantification of proteins in various biological samples. - Multi-Omics Approaches:
There is a significant emphasis on integrating proteomics with other omics technologies (genomics, metabolomics, etc.) to provide a holistic understanding of biological processes and disease mechanisms. - Disease Mechanisms and Biomarker Discovery:
Research published in the journal often aims at elucidating disease mechanisms and identifying potential biomarkers for various conditions, including cancers, metabolic disorders, and infectious diseases. - Innovative Methodologies:
The journal encourages the development and application of novel proteomic methodologies, including advanced labeling techniques, data-independent acquisition, and machine learning approaches for data analysis. - Functional Proteomics:
There is a strong focus on functional proteomics, exploring protein interactions, modifications, and their roles in cellular processes and disease pathology. - Comparative Proteomics:
The journal publishes studies that involve comparative analyses of proteomes across different species, conditions, or treatments, contributing to evolutionary biology and translational research.
Trending and Emerging
- Machine Learning and Computational Proteomics:
There is an increasing trend towards the application of machine learning and computational techniques in proteomics for data analysis, modeling, and predicting protein interactions and functions. - Clinical Applications and Translational Research:
Research aimed at clinical applications, particularly in biomarker discovery for diseases such as cancer, metabolic disorders, and neurological diseases, is on the rise, emphasizing the importance of proteomics in personalized medicine. - Environmental and Ecological Proteomics:
Emerging studies are focusing on the proteomic responses of organisms to environmental stressors, showcasing the application of proteomics in ecology and environmental science. - Proteomics in Regenerative Medicine and Stem Cell Research:
There is a growing interest in the role of proteomics in regenerative medicine and stem cell research, exploring how protein expression profiles can inform cell differentiation and tissue engineering. - Functional and Structural Proteomics:
The journal is seeing a rise in studies that explore the functional and structural aspects of proteins, including post-translational modifications and protein-protein interactions, which are crucial for understanding biological processes.
Declining or Waning
- Basic Protein Characterization:
There has been a noticeable decrease in studies focused solely on basic protein characterization without a clear application or connection to disease mechanisms or functional insights. - Single-Omics Studies:
Research solely focused on proteomics without integration with other omics approaches is becoming less common, as the trend moves toward multi-omics studies that provide more comprehensive insights. - Traditional Proteomic Techniques:
The reliance on traditional proteomic techniques, such as two-dimensional gel electrophoresis, appears to be waning in favor of more advanced and high-throughput methods, including mass spectrometry-based techniques. - Descriptive Studies:
There is a decline in purely descriptive studies that lack hypothesis-driven research or significant biological implications, as the field moves towards more application-oriented research.
Similar Journals
Clinical Proteomics
Exploring the Frontiers of Proteomics in MedicineClinical Proteomics is a leading open-access journal, published by BMC since 2011, that aims to advance the field of proteomics by providing a platform for the dissemination of original research, critical reviews, and technological advancements in the analysis of proteins and their roles in health and disease. With an ISSN of 1542-6416 and E-ISSN 1559-0275, this esteemed journal covers a broad scope, converging years of research from 2004 to 2024. As a distinguished publication, it holds a Q1 ranking in Clinical Biochemistry and Q2 in both Molecular Biology and Molecular Medicine, reflecting its significance in the scientific community. Clinical Proteomics' commitment to open access ensures that its content is readily available to researchers, professionals, and students worldwide, facilitating the exchange of knowledge and fostering collaborative efforts in proteomic studies. Situated in the United Kingdom, this journal plays a pivotal role in shaping the future of biomedical research, appealing to anyone keen on the integration of proteomics in clinical practice and molecular investigation.
PROTEIN AND PEPTIDE LETTERS
Advancing molecular insights through protein and peptide research.PROTEIN AND PEPTIDE LETTERS is a prominent peer-reviewed journal published by Bentham Science Publishers Ltd, specializing in the dynamic fields of biochemistry and structural biology. With an ISSN of 0929-8665 and a corresponding E-ISSN of 1875-5305, the journal has been a pivotal platform for researchers since its inception in 1994. Spanning various aspects of protein and peptide research, it aims to disseminate groundbreaking findings that enhance our understanding of molecular mechanisms and therapeutic applications. Although categorized in the Q3 quartile for biochemistry and medicine, and Q4 in structural biology within the 2023 metrics, it remains a valuable resource in the academic arena, offering insight into the latest research and advancements. As the journal converges towards its 2024 milestone, it continues to reflect the evolving landscape of molecular research. While it currently does not offer open access, the accessibility to its impactful content is essential for students, professionals, and researchers invested in these critical scientific disciplines.
All Life
Exploring the Intersections of Life SciencesAll Life is a distinguished academic journal published by TAYLOR & FRANCIS LTD, based in the United Kingdom, focusing on the interdisciplinary realms of agricultural and biological sciences, biochemistry, genetics, and neuroscience. With the ISSN 2689-5293 and E-ISSN 2689-5307, this open-access journal aims to disseminate high-quality research from 2020 to 2024, facilitating a wider reach and impact across various fields. Notably, it holds a Q3 ranking in both Agricultural and Biological Sciences, as well as Biochemistry, Genetics and Molecular Biology, and a Q4 ranking in Neuroscience, reflecting its growing presence in these disciplines. All Life aims to foster collaboration among researchers, professionals, and students, encouraging innovative approaches in understanding life sciences. By delivering timely insights and thought-provoking discussions, the journal plays a crucial role in advancing knowledge and promoting interdisciplinary dialogue in the evolving landscape of life sciences research.
COMPUTATIONAL BIOLOGY AND CHEMISTRY
Empowering Researchers to Navigate the Frontiers of Computational Biology and ChemistryCOMPUTATIONAL BIOLOGY AND CHEMISTRY is a distinguished academic journal published by Elsevier Science Ltd, focusing on the dynamic intersection of computational biology, biochemistry, and chemistry. With an ISSN of 1476-9271 and an E-ISSN of 1476-928X, this journal is committed to disseminating high-quality research that employs computational techniques to solve complex biological and chemical problems. As of 2023, the journal holds a substantial impact factor reflecting its significance and rigorous peer-review process, categorized in the Q2 quartile for both Computational Mathematics and Organic Chemistry, alongside Q3 classifications in Biochemistry and Structural Biology. With a continuous publication history spanning from 2003 to 2024, it serves as a critical resource for researchers, professionals, and students alike. The journal offers various open access options, ensuring that vital research findings are accessible to a global audience, further enhancing collaboration across disciplines. Engage with cutting-edge studies and contribute to the evolving landscape of computational methodologies in the life sciences through this esteemed publication.
BIOCHEMISTRY-MOSCOW
Championing Groundbreaking Studies in Life SciencesBIOCHEMISTRY-MOSCOW is a distinguished academic journal published by MAIK NAUKA/INTERPERIODICA/SPRINGER, focusing on pivotal research in the fields of biochemistry, biophysics, geriatrics, and broader medical sciences. Established in 1972, the journal has a rich history of disseminating critical findings and innovative studies, making significant contributions to the advancement of biochemical knowledge and applications. With its Q2 ranking in various categories including biochemistry and gerontology, the journal commands respect within the scientific community, offering a reputable platform for both established researchers and emerging scholars alike. Although traditionally not an open-access journal, it provides a wealth of information accessible through institutional subscriptions, ensuring the latest advancements reach a global audience. The journal aims to enhance understanding of biochemical processes and their implications for human health, and its commitment to high-quality peer-reviewed content has established it as a vital resource for those invested in the life sciences.
Doklady Biochemistry and Biophysics
Illuminating the Science Behind Biochemical Processes and Physical PrinciplesDoklady Biochemistry and Biophysics is a vital resource for the advancement of knowledge in the fields of biochemistry and biophysics, published by MAIK NAUKA/INTERPERIODICA/SPRINGER. Featuring an ISSN of 1607-6729 and an E-ISSN of 1608-3091, this journal plays a critical role in disseminating research findings and fostering scholarly discourse. Despite its recent ranking in the Q4 quartile for biochemistry and biophysics in 2023, it serves as an essential platform for researchers exploring these intertwined disciplines. The journal’s scope encompasses a wide variety of topics, enhancing the understanding of biochemical processes and physical principles in biological systems. With converged years of publication from 2001 to 2024, it stands as a continual source of knowledge for its readers, who include researchers, professionals, and students alike. While the journal currently does not offer open access options, its contributions remain significant within the scholarly community, illustrated by its competitive Scopus rankings across related fields.
Molecular Omics
Bridging Disciplines for Tomorrow's DiscoveriesMolecular Omics is a premier, peer-reviewed journal published by the Royal Society of Chemistry, focusing on the interdisciplinary field of molecular biology with significant implications for biochemistry and genetics. With an E-ISSN of 2515-4184, this journal has been dedicated to disseminating high-quality research since its inception in 2018, maintaining an impressive trajectory in academic contributions until 2024. Currently, it holds a Q2 quartile ranking in both Biochemistry and Genetics, alongside a Q3 ranking in Molecular Biology for 2023, highlighting its relevance and influence in these domains. The journal is accessible as an open access publication, promoting the widespread dissemination of groundbreaking research. As part of a vibrant academic community, Molecular Omics aims to bridge fundamental and applied science, appealing to researchers, professionals, and students eager to expand their knowledge on molecular mechanisms and technologies that shape the future of biological research.
MOLECULAR & CELLULAR PROTEOMICS
Advancing the frontiers of protein science.MOLECULAR & CELLULAR PROTEOMICS, published by Elsevier, stands as a premier journal in the fields of Biochemistry, Analytical Chemistry, and Molecular Biology, with a distinguished Q1 ranking reflecting its high impact and contribution to the scientific community. Established in 2002, this journal has consistently provided a platform for the latest research in protein science, merging molecular biology with advanced analytical techniques. With impressive Scopus rankings—41st in Biochemistry and 16th in Analytical Chemistry—it caters to an audience of researchers, professionals, and students eager to explore cutting-edge developments in proteomics. Although currently not designated as open access, the journal aims to foster knowledge dissemination through accessible research content. As it continues to evolve until 2024, MOLECULAR & CELLULAR PROTEOMICS is essential for anyone passionately engaged in the ever-expanding field of proteomics.
Cell Reports Methods
Bridging Disciplines for Impactful Scientific ProgressCell Reports Methods is a cutting-edge journal published by CELL PRESS, focusing on innovative methodologies in the vast fields of biochemistry, genetics, biotechnology, and radiological sciences. Launched in 2021, it has rapidly ascended to attain a Q1 ranking across multiple disciplines in the latest 2023 metrics, reflecting its influential contribution to the scientific community. With an emphasis on practical and rigorous experimental approaches, this journal serves as a vital resource for researchers looking to advance their methodologies and collaborate on significant findings in their respective specialties. Despite not being an open-access publication, Cell Reports Methods ensures broad accessibility through institutional subscriptions, allowing researchers from various backgrounds to engage with high-quality scholarly work. The journal presents a unique platform for sharing insights from interdisciplinary methods that foster innovation and discovery, ultimately shaping the future of scientific research.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
Unveiling the complexities of molecular life.BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, published by Academic Press Inc Elsevier Science, stands as a leading periodical in the fields of biochemistry, biophysics, cell biology, and molecular biology. With an ISSN of 0006-291X and an E-ISSN of 1090-2104, this esteemed journal has been a pivotal platform for the dissemination of groundbreaking research since its inception in 1959, continuing to publish influential findings through at least 2024. It holds a commendable Q2 ranking in Biochemistry and Q1 status in Biophysics as of 2023, reflecting its high impact and relevance in the field, supported by its strong Scopus rankings—ranking #43 in Biophysics and maintaining a presence in the top quartiles of several related categories. Although it is not an open-access journal, it provides critical insights and essential data that cater to researchers, professionals, and students keen on advancing their understanding of complex biochemical and biophysical processes. Its significant contributions to the scientific community underscore the importance of this journal as a reference point for innovative research and collaborative discourse.